Project Grant R01HS029677
Award Date
9/30/24
Completion Date
7/31/29
Dollars Obligated
$286K
Funding Federal Agency
Center for Evidence and Practice Improvement
Awarding Federal Agency
Division of Grants Management
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.226
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This federal Project Grant award of $796,293 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to establish the role of autoimmune pathogenesis in certain forms of nephrotic syndrome, specifically minimal change disease and focal segmental glomerulosclerosis. The research aims to characterize the immunophenotypes and pathomechanistic effects of...
The U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality (AHRQ) awarded a $153,050 Project Grant under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program to The Children's Hospital Corporation (doing business as Boston Children's Hospital). The grant, with a period of performance from July 1, 2024 to June 30, 2029, will fund the development and implementation of a machine learning prediction model to identify children at high risk for...
This federal Project Grant award of $2,057,241 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to conduct a Type 1 hybrid effectiveness-implementation study of the "Hypospadias Hub" intervention. The study, led by the University of North Carolina at Chapel Hill, will assess the effectiveness of the Hypospadias Hub in improving shared decision-making...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $312,198 to the University of California, San Francisco (UCSF) to elucidate patterns of cardiovascular disease risk in adolescent and young adult patients with kidney disease. The key objectives are to understand barriers to implementation of cardiovascular risk reduction therapies and test the acceptability and clinical utility of...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program provides $275,000 to the University of Texas Health Science Center at Houston over a 2-year period from August 1, 2024 to July 31, 2026. The funded project aims to develop and test strategies to increase implementation of evidence-based interventions by patient advocacy groups in three areas: juvenile idiopathic arthritis, multiple...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $3,232,478 to Case Western Reserve University for the "Assessment of the Impact of Antihypertensive Medications on Vascular and Renal Outcomes in Chronic Kidney Disease (AIM-CKD)" research project. The goal is to leverage data from two extensive studies, the Chronic Renal Insufficiency Cohort (CRIC) and the Systolic Blood...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $234,000.00 to the University of Colorado-Denver to develop and pilot a patient decision aid (DA) to support shared decision-making for pharmacologic treatments of dementia. The key products and services to be delivered include: Conducting a qualitative needs assessment on decision-making for dementia therapies among patients, caregivers, and clinicians. Simultaneously developing a patient DA...
The University of Utah was awarded a $167,455 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The 5-year grant, commencing on September 18, 2024, aims to create and pilot a set of surgical decision aids (DAs) to facilitate shared decision-making (SDM) for adolescents and young adults (AYAs) with differences of sex development (DSD) and their caregivers. The project's...
This Project Grant award, valued at $155,274, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research conducted by Emory University to investigate the neurovascular mechanisms underlying accelerated kidney disease progression in older adults with chronic kidney disease (CKD). The key objectives of this 4-year research project are to: 1)...
This $200,000 Project Grant awarded on September 17, 2024 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA Program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research supports a case-cohort study to identify novel risk factors for end-stage kidney disease (ESKD) among living kidney donors. The study aims to improve the counseling and selection of living kidney donors by developing tailored risk prediction tools based on donor...